KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients

Maurizio Martini, Alessandra Cassano, Luigi Maria Larocca, Michele Basso, Antonia Strippoli, Armando Orlandi, Maria Alessandra Calegari, Giovanni Schinzari, Mariantonietta Di Salvatore, Tonia Cenci, Carlo Antonio Barone

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences